@article {C7DT01955F,
	title = {A Perspective - can copper complexes be developed as a novel class of therapeutics?},
	journal = {Dalton Trans.},
	volume = {46},
	year = {2017},
	pages = {10758-10773},
	publisher = {The Royal Society of Chemistry},
	abstract = {Although copper-ligand complexes appear to be promising as a new class of therapeutics{,} other than the family of copper(ii) coordination compounds referred to as casiopeinas these compounds have yet to reach the clinic for human use. The pharmaceutical challenges associated with developing copper-based therapeutics will be presented in this article along with a discussion of the potential for high-throughput chemistry{,} computer-aided drug design{,} and nanotechnology to address the development of this important class of drug candidates.},
	doi = {10.1039/C7DT01955F},
	url = {http://dx.doi.org/10.1039/C7DT01955F},
	author = {Wehbe, Mohamed and Leung, Ada W. Y. and Abrams, Michael J. and Orvig, Chris and Bally, Marcel B.}
}
